CN Patent

CN110833539A — 超低密度的肺部粉末

Assigned to Mertz Pharmaceutical Co.,Ltd. · Expires 2020-02-25 · 6y expired

What this patent protects

本发明的名称是超低密度的肺部粉末。本发明提供用于肺部递送的包含颗粒的药物组合物，所述颗粒含有药剂，并且具有大于约5μm的几何尺寸和小于约0.075g/cm 3 的振实密度。本发明还提供用于递送本发明的药物组合物至患者呼吸道的方法。

USPTO Abstract

本发明的名称是超低密度的肺部粉末。本发明提供用于肺部递送的包含颗粒的药物组合物，所述颗粒含有药剂，并且具有大于约5μm的几何尺寸和小于约0.075g/cm 3 的振实密度。本发明还提供用于递送本发明的药物组合物至患者呼吸道的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110833539A
Jurisdiction
CN
Classification
—
Expires
2020-02-25
Drug substance claim
No
Drug product claim
No
Assignee
Mertz Pharmaceutical Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.